Related references
Note: Only part of the references are listed.Role of Toll-like receptors in the pathogenesis of COVID-19
Shaghayegh Khanmohammadi et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Toll-Like Receptor 7 Stimulation Promotes the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice
Alexander O. Krogmann et al.
INTERNATIONAL HEART JOURNAL (2020)
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Role of TLR4 in physical exercise and cardiovascular diseases
Larissa G. de Vicente et al.
CYTOKINE (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The Role of Toll-like Receptors in Atherothrombotic Cardiovascular Disease
Ying Zhou et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction
Dominique P. V. de Kleijn et al.
CARDIOVASCULAR RESEARCH (2019)
Targeting the Immune System in Atherosclerosis
Tian X. Zhao et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The role of platelets in mediating a response to human influenza infection
Milka Koupenova et al.
NATURE COMMUNICATIONS (2019)
Siglec-1 Macrophages and the Contribution of IFN to the Development of Autoimmune Congenital Heart Block
Robert M. Clancy et al.
JOURNAL OF IMMUNOLOGY (2019)
Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial
HamidReza Pourhosseini et al.
IJC HEART & VASCULATURE (2019)
Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque
Roberto Carnevale et al.
SCIENTIFIC REPORTS (2018)
Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies
Cristina Cappelletti et al.
NUCLEUS (2018)
Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy
Lifang Zhao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Up-regulation of Toll-like receptors 7 and 9 and its potential implications in the pathogenic mechanisms of LMNA-related myopathies
Cristina Cappelletti et al.
NUCLEUS (2018)
Platelets in Immune Response to Virus and Immunopathology of Viral Infections
Eugenio D. Hottz et al.
FRONTIERS IN MEDICINE (2018)
Low TLR7 gene expression in atherosclerotic plaques is associated withmajor adverse cardio- and cerebrovascular events
Glykeria Karadimou et al.
CARDIOVASCULAR RESEARCH (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Design and Synthesis of N1-Modified Imidazoquinoline Agonists for Selective Activation of Toll-like Receptors 7 and 8
Peter Larson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
Laure Perrin-Cocon et al.
SCIENTIFIC REPORTS (2017)
Endosomal Toll-like receptors inclinically overt and silent autoimmunity
Robert M. Clancy et al.
IMMUNOLOGICAL REVIEWS (2016)
NETosis markers: Quest for specific, objective, and quantitative markers
Saldko Masuda et al.
CLINICA CHIMICA ACTA (2016)
Immune system and cardiovascular disease
Irene Fernandez-Ruiz
NATURE REVIEWS CARDIOLOGY (2016)
Toll-Like Receptor 7-Targeted Therapy in Respiratory Disease
Katie M. Lebold et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2016)
TLR signalling and association of TLR polymorphism with cardiovascular diseases
Swati Sharma et al.
VASCULAR PHARMACOLOGY (2016)
Cardiac RNA Induces Inflammatory Responses in Cardiomyocytes and Immune Cells via Toll-like Receptor 7 Signaling
Yan Feng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Inflammation and plaque vulnerability
G. K. Hansson et al.
JOURNAL OF INTERNAL MEDICINE (2015)
Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma
Fatma E. Mohamed et al.
LIVER INTERNATIONAL (2015)
Low-Density Lipoprotein-Cholesterol-Induced Endothelial Dysfunction and Oxidative Stress: The Role of Statins
Nerea Hermida et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis
Mohammad Zare-Bidaki et al.
VIRAL IMMUNOLOGY (2014)
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Peter Libby et al.
IMMUNITY (2013)
The history of Toll-like receptors - redefining innate immunity
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Blocking Toll-Like Receptors 7 and 9 Reduces Postinterventional Remodeling via Reduced Macrophage Activation, Foam Cell Formation, and Migration
Jacco C. Karper et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining Inflammatory Macrophage Activation
Maria Salagianni et al.
CIRCULATION (2012)
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo
Norliana Khairuddin et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Role of Toll-like receptors in cardiovascular diseases
Jesus G. Vallejo
CLINICAL SCIENCE (2011)
Toll-like receptors as potential therapeutic targets in cardiac dysfunction
Ulrich Hofmann et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Innate immune signaling in cardiac ischemia
Fatih Arslan et al.
NATURE REVIEWS CARDIOLOGY (2011)
Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis
Philippe P. Pagni et al.
AUTOIMMUNITY (2010)
Ro60-Associated Single-Stranded RNA Links Inflammation with Fetal Cardiac Fibrosis via Ligation of TLRs: A Novel Pathway to Autoimmune-Associated Heart Block
Robert M. Clancy et al.
JOURNAL OF IMMUNOLOGY (2010)
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Taro Kawai et al.
NATURE IMMUNOLOGY (2010)
Statins inhibit Rho kinase activity in patients with atherosclerosis
Anju Nohria et al.
ATHEROSCLEROSIS (2009)
Toll-like receptors and innate immunity
Himanshu Kumar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Innate Immunity and Toll-like Receptor Antagonists: A Potential Role in the Treatment of Cardiovascular Diseases
Elaine Lin et al.
CARDIOVASCULAR THERAPEUTICS (2009)
The potential use of toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents
Amani Makkouk et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Recognition of viral single-stranded RNA by Toll-like receptors
Sandra S. Diebold
ADVANCED DRUG DELIVERY REVIEWS (2008)
Toll-like receptor modulation: A novel therapeutic strategy in cardiovascular disease?
Athanasios Katsargyris et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes
Valentina Loria et al.
MEDIATORS OF INFLAMMATION (2008)
TLR signaling by tumor and immune cells: a double-edged sword
B. Huang et al.
ONCOGENE (2008)
Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists
Woubalem Birmachu et al.
BMC IMMUNOLOGY (2007)
2'-O-methyl-modified RNAs act as TLR7 antagonists
Marjorie Robbins et al.
MOLECULAR THERAPY (2007)
Fimbrial proteins of Porphyromonas gingivalis mediate in vivo virulence and exploit TLR2 and complement receptor 3 to persist in macrophages
Min Wang et al.
JOURNAL OF IMMUNOLOGY (2007)
A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease
Anastassios Manolakis et al.
HELICOBACTER (2007)
A Tlr7 translocation accelerates systemic autoimmunity in murine lupus
Srividya Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
MyD88 signaling controls autoimmune myocarditis induction
RR Marty et al.
CIRCULATION (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Modulation of atherosclerosis in mice by Toll-like receptor 2
AE Mullick et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent
K Triantafilou et al.
CELLULAR MICROBIOLOGY (2005)
Toll-like receptors, endogenous ligands, and systemic autoimmune disease
IR Rifkin et al.
IMMUNOLOGICAL REVIEWS (2005)
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction
S Uematsu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
SS Diebold et al.
SCIENCE (2004)
Inflammation as a cardiovascular risk factor
JT Willerson et al.
CIRCULATION (2004)
Induction of systemic TH1-like innate immunity in normal volunteers following subcutaneous but not intravenous administration of CPG 7909, a synthetic B-Class CpG oligodeoxynucleotide TLR9 agonist
AM Krieg et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Cytokine polymorphisms and histologic expression in autopsy studies:: Contribution of TNF-α and TGF-β1 to the pathogenesis of autoimmune-associated congenital heart block
RM Clancy et al.
JOURNAL OF IMMUNOLOGY (2003)
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets
P Libby et al.
NATURE MEDICINE (2002)
Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block
LE Nield et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
H Hemmi et al.
NATURE IMMUNOLOGY (2002)
Statins: Effective antiatherosclerotic therapy
RS Blumenthal
AMERICAN HEART JOURNAL (2000)
Share Paper
